33-year-old-woman
15-week size fibroid uterus not desiring fertility; Prior vaginal deliveries; One prior pelvic surgery.
Symptoms: Heavy menses; Increased urinary frequency; Dyspareunia (painful intercourse);
Ultrasound: Uterus with multiple fibroids
Examination: 15-week.

• Current Opinion Pregnancy after UFE v Myomectomy
• Role of Interventional Radiology in Women's Health
• Cost and Reimbursement for Three Fibroid Treatments
• Fertility Sparing Treatment Options for Women with Symptomatic Fibroids
• Minimally Invasive Treatment Options for Uterine Fibroids
• UAE Complicated by Nontarget Labial Embolization
• Delayed Leiomyoma Degeneration After Microwave Endometrial Ablation
• Uterine Artery Embolization for Symptomatic Fibroids
• Premyomectomy UFE for Massive Uterine Enlargement
• Leiomyosarcoma in a Premenopausal Patient After UFE
• UAE for Symptomatic Leiomyomata
• Pregnancy Outcomes after UFE v Laparoscopic Myomectomy
• Small Bowel Obstruction Following UFE
• UFE: A Hidden Alternative
• Pregnancy After Uterine Artery Embolization

1. Yeagley T, Goldberg J, Klein T, Bonn J. Labial necrosis after uterine artery embolization for leiomyomas. Obstet Gynecol 2002;100(5):881.
2. Goldberg J, Berghella V, Pereira L. Pregnancy after uterine artery embolization. Obstet Gynecol 2002;100:869-72.
3. Sultana CJ, Goldberg J, Aizenman L, Chon JK. Vesicouterine fistula after uterine artery embolization: A case report. Am J Obstet Gynecol 2002;187:1726-7.
4. Goldberg J. Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. Letter to the editor. Obstet Gynecol 2002;99:1134-5.
5. Goldberg J, Pereira L, Mude-Nochumson H. Uterine artery embolization for symptomatic fibroids. OBG Management, April 2003:69-79.
6. Muffly T, Goldberg J, Goldberg B. Leiomyoma degeneration during pregnancy masquerading as uterine rupture. Female Patient 2003;28:53-4.
7. Gopal M, Goldberg J, Klein T, Fossum G. Embolization of uterine arteriovenous malformation followed by a twin pregnancy. Obstet Gynecol 2003;102:696-8.
8. Mude-Nochumson H, Goldberg J. Fertility-sparing treatment options for women with symptomatic fibroids. Female Patient 2003;28:21-6.
9. Goldberg J, Pereira L, Diamond J, Berghella V, Daraï E, Seinera P, Seracchioli R. Pregnancy outcomes following treatment for fibroids: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol 2004;191:18-21.
10. Goldberg J, Burd I, Price FV, Worthington-Kirsch R. Leiomyosarcoma in a pre-menopausal patient following uterine artery embolization. Am J Obstet Gynecol 2004;191:1733-5.
11. Goldberg J. Uterine fibroid embolization: a hidden alternative? Obstet Gynecol Surv 2005;60:209-10.
12. Goldberg J, Ness A, Fossum G. Does uterine fibroid embolization need to be offered as a treatment alternative? Pros and cons. Contemp OB/GYN 2005;6:78-84.
13. Goldberg J. Pregnancy after uterine artery embolization for leiomyomata: The Ontario Multicenter Trial. Letter to the editor. Obstet Gynecol 2005;106:195-6.
14. Goldberg J. Uterine artery embolization for adenomyosis: looking at the glass half full. Radiology 2005;236:1111-2.
15. Goldberg J, McCrosson S, Kaulback KR. Fibroid degeneration following microwave endometrial ablation. Obstet Gynecol 2005;106:1176-8.
16. Goldberg J, Boyle K, Choi M, Panchal N. Bowel obstruction following uterine fibroid embolization. Am J Obstet Gynecol 2005;193:892-3.
17. Goldberg J. Uterine fibroid embolization: A new treatment for uterine fibroids. Female Patient 2006;31:45-50.
18. Goldberg J, Mella MT. Uterine fibroid embolization complicated by non-target labial embolization. Female Patient 2006;31:26-7.
19. Goldberg J, Pereira L. Pregnancy outcomes following uterine fibroid embolization and myomectomy. Current Opin Ob Gyn 2006;18:402-6.
20. Goldberg J, Bromberg J, Srinivasan S. Minimally invasive treatment options for uterine fibroids. JCOM 2006;13:518-25.
21. Goldberg J, Cothran S, Bonn J. Pre-myomectomy uterine fibroid embolization for a massively enlarged fibroid uterus. Female Patient 2006;31:1-3.
22. Goldberg J, Bussard A, McNeil J, Diamond J. Cost and reimbursement for three fibroid treatments: Abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization. CVIR 2007; 30:54-8.
23. Goldberg J. Current thinking on the role of interventional radiology in women’s health. Expert Opin Gyn Obstet 2007;2:621-9.
24. Wiehle R, Goldberg J, Brodzniewicz T, Jarus-Dziedzric K, Jabiry-Zieniewicz Z. Effects of a new progesterone receptor modulator, CDB-4124, on fibroid size and uterine bleeding. US Obstet Gynecol 2008;17-20.
25. McConnell S, Goldberg J, Gonsalves C. Myometrial Air Infiltration Following Postpartum Uterine Artery Embolization. Female Patient 2009;34:36-8.
26. Goldberg J. Letter to the Editor: Advanced ovarian carcinoma following bilateral uterine artery embolization. J Reprod Med 2010; 55:179.

1. Goldberg J. Fertility and pregnancy: uterine fibroids: treatment options. www. Ivanhoe.com/fertility, February 2003.
2. McCrosson S, Goldberg J. A generalist OB/GYN’s approach to infertility. Treatment plans for ART. The American Infertility Association, Fall 2004.
3. Goldberg J. Chapter: The role of Interventional Radiology in women’s health: an OB/GYN perspective. Siskin’s Interventional Radiology in Women’s Health, 2009.

1. Goldberg J. Pregnancy after myomectomy and uterine artery embolization. Int J Gyn Obstet 2003;83(S3):10.
2. Goldberg J, Pereira L, Berghella V, Daraï E, Seinera P, Seracchioli R, Diamond J. Uterine artery embolization versus laparoscopic myomectomy: future pregnancy outcomes. Int J Gyn Obstet 2003;83(S3):87.
3. Goldberg J, Pereira L, Berghella V, Daraï E, Seinera P, Seracchioli R, Diamond J. Uterine artery embolization versus laparoscopic myomectomy: future pregnancy outcomes. Obstet Gynecol 2004;103:30S.
4. Bromberg JV, Goldberg J, Rychlak K, Weinstein L. The effect of uterine fibroids on pregnancy outcomes. Proceedings of the Advances in Uterine Leiomyoma Research: NIH 2nd International Congress, Bethesda, February 2005.
5. Seibel-Seamon J, Ness A, Goldberg J. Uterine fibroid embolization complications reported in the scientific literature and the FDA’s MAUDE database. Proceedings of the Advances in Uterine Leiomyoma Research: NIH 2nd International Congress, Bethesda, February 2005.
6. Bussard A, Goldberg J, McNeil J, Diamond J. Cost and reimbursement for three fibroid treatments: hysterectomy, myomectomy, and uterine fibroid embolization. Proceedings of the Advances in Uterine Leiomyoma Research: NIH 2nd International Congress, Bethesda, February 2005.
7. Seibel-Seamon J, Ness A, Goldberg J. Uterine fibroid embolization complications reported in the scientific literature and the FDA’s MAUDE database. Obstet Gynecol 2005;105:25S.
8. Bussard A, Goldberg J, McNeil J, Diamond J. Cost and reimbursement for three fibroid treatments: hysterectomy, myomectomy, and uterine fibroid embolization. Obstet Gynecol 2005;105:7S.
9. Johnston-MacAnanny E, Goldberg J, Bromberg JV, Diamond J, Weinstein L. Natural progression of uterine fibroid size: a comparison of pregnancy and post-pregnancy volumes. J Min Invasive Gynecol 2005;12:S50.
10. McConnel S, Goldberg J, Gonsalves C. Myometrial Air Infiltration Following Postpartum Uterine Artery Embolization. J Min Invasive Gynecol 2007;14:S127.
11. Pham C, Diamond JJ, Goldberg J. Concurrent use of transabdominal endometrial ablation and abdominal myomectomy. J Min Invasive Gynecol 2007;14:S132.
12. Hellman M, Angelo J, Diamond J, Goldberg J. Perceptions of patients desiring future fertility of two leiomyoma treatments: Myomectomy and Uterine Leiomyoma Embolization. Obstet Gynecol 2008;111;23S.
13. Hellman M, Angelo J, Diamond J, Goldberg J. Perceptions of patients with leiomyomata not desiring future fertility of Hysterectomy, Myomectomy and Uterine Leiomyoma Embolization. Obstet Gynecol 2008; 111;27S.
14. Harrington C, Dayaratna S, Goldberg J. Cost and reimbursement for robotic, laparoscopic, and vaginal hysterectomy. J Min Invasive Gynecol 2011.

“A Phase III, open-label, parallel, randomized, multicenter study evaluating the safety of 25 and 50 mg Proellex (CDB-4124) in the treatment pre-menopausal women with symptomatic uterine fibroids.”
Primary Investigator: Jay Goldberg, MD, MSCP. Sponsor: Repros Therapeutics, Inc.

“A Phase II, multicenter, randomized, placebo-controlled, double-blinded study of the selective progesterone receptor modulator Proellex (CDB-4124) in pre-menopausal women with symptomatic leiomyomata.”
Primary Investigator: Jay Goldberg, MD, MSCP. Sponsor: Repros Therapeutics, Inc.

“A study to examine the safety, tolerability and efficacy of 2 doses of Aprepitant for the prevention of postoperative nausea and vomiting.”
Sub-Investigator. PI: Thomas Witkowski, MD. Sponsor: Merck & Co., Inc.

“Comparison of the safety and efficacy of patient controlled analgesia delivered by fentanyl HCI transdermal system versus morphine IV pump for pain management after non-emergent lower abdominal and pelvic surgery.”
Sub-Investigator. PI: Thomas Witkowski, MD. Sponsor: PharmaNet, Inc.

“A Phase III study of intravenous acetaminophen vs placebo over 48 hours for the treatment of postoperative pain after gynecologic surgery”
Sub-Investigator. PI: Eugene Viscusi, MD. Sponsor: Cadence Pharmaceuticals.

“A randomized, double-blind, double-dummy, dose ranging, active- and placebo controlled study of single dose oral rolapitant monotherapy for the prevention of postoperative nausea and vomiting.”
Sub-Investigator. PI: Eugene Viscusi, MD. Sponsor: Schering-Plough

“A double-blind, placebo-controlled, multicenter trial to study the efficacy and tolerability of MK-0663/Etoricoxib in treatment of pain after abdominal hysterectomy.”
Sub-Investigator. PI: Thomas Witkowski, MD. Sponsor: Merck & Co., Inc.

2003 - present Manuscript Referee, Obstetrics & Gynecology
 Manuscript Referee, Medical Science Monitor
 Manuscript Referee, Springer-Verlag London Ltd. Publishers

---

2004 K30 Observing Editor, Annals of Internal Medicine

---

2005 - present Manuscript Referee, Journal of Perinatology
 Manuscript Referee, Human Reproduction
 Manuscript Referee, Female Patient
 Manuscript Referee, American Journal of Obstetrics & Gynecology

---

2006 - present Manuscript Referee, British Journal of Obstetrics & Gynecology
 Manuscript Referee, Canadian Medical Association Journal
 Manuscript Referee, Internet Journal of Family Practice
 Manuscript Referee, Archives of Gynecology and Obstetrics

---

2007 - present Manuscript Referee, Women’s Health
 Manuscript Referee, Future Drugs
 Manuscript Referee, Future Medicine
 Manuscript Referee, Journal of Obstetrics and Gynaecology Research
 Manuscript Referee, Medscape General Medicine

---

2008 - present Manuscript Referee, Journal of Women’s Health

---

2009 - present Manuscript Referee, Expert Review of Obstetrics & Gynecology
 Manuscript Referee, Reproductive Sciences
 Manuscript Referee, Medical Case Studies

---

2011 - present Manuscript Referee, Journal of Medical Case Reports
 Manuscript Referee, African Journal of Pharmacy and Pharmacology
 Manuscript Referee, Journal of Clinical Medicine and Research

Harrington C, Dayaratna S, Goldberg J. Cost and reimbursement for robotic, laparoscopic, and vaginal hysterectomy. Oral presentation. 40th Global Congress of Minimally Invasive Gynecology, Florida, 2011.

Harrington C, Dayaratna S, Goldberg J, Leiby B, McNeil J. Potential cost savings of performing TVH over other minimally invasive hysterectomies. TJU Resident & Fellow Research Day. Philadelphia, April 28, 2011.

Femiano D, Hellman M, Diamond JJ, Angelo J, Goldberg J. Internet effects on patient familiarity and perceptions of fibroid treatments. TJUH AOA Research Day, Philadelphia, November 7, 2008.

Goldberg J. Proellex®: a novel treatment for uterine fibroids. Repros Therapeutics Investor Day, New York City, July 24, 2008.

Hellman M, Angelo J, Diamond J, Goldberg J. Perceptions of patients desiring future fertility of two leiomyoma treatments: Myomectomy and Uterine Leiomyoma Embolization. ACOG Annual Clinical Meeting, New Orleans, May 2008.

Hellman M, Angelo J, Diamond J, Goldberg J. Perceptions of patients with leiomyomata not desiring future fertility of Hysterectomy, Myomectomy and Uterine Leiomyoma Embolization. ACOG Annual Clinical Meeting, New Orleans, May 2008.

McConnel S, Goldberg J. Myometrial Air Infiltration Following Postpartum Uterine Artery Embolization. 36th Global Congress of Minimally Invasive Gynecology, Washington, DC, Nov. 2007.

Pham C, Diamond JJ, Goldberg J. Concurrent use of transabdominal endometrial ablation and abdominal myomectomy. 36th Global Congress of Minimally Invasive Gynecology, Washington, DC, Nov. 2007.

Goldberg J. Uterine fibroid embolization update. Lunch presentation, ACOG Annual Clinical Meeting, San Diego, CA, May 2007.

Goldberg J. Uterine fibroid update 2007. Repros Therapeutics R&D Day, New York City, January 4, 2007.

Goldberg J. Interim data of Proellex® uterine fibroid trial. Repros Therapeutics R&D Day, New York City, January 4, 2007.

Goldberg J. Uterine fibroid embolization update. Lunch presentation, ACOG Annual Clinical Meeting, Washington, DC, May 2006.

Johnston-MacAnanny E, Goldberg J, Bromberg JV, Diamond J, Weinstein L. Natural progression of uterine fibroid size: a comparison of pregnancy and post-pregnancy volumes. AAGL, Chicago, 2005.

Seibel-Seamon J, Ness A, Goldberg J. Uterine fibroid embolization complications reported in the scientific literature and the FDA’s MAUDE database. ACOG Annual Clinical Meeting, San Francisco, May 2005.

Bussard A, Goldberg J, McNeil J, Diamond J. Cost and reimbursement for three fibroid treatments: hysterectomy, myomectomy, and uterine fibroid embolization. ACOG Annual Clinical Meeting, San Francisco, May 2005.

Bromberg JV, Goldberg J, Rychlak K, Weinstein L. The effect of uterine fibroids on pregnancy outcomes. NIH 2nd Annual International Fibroid Congress, Bethesda, February 2005.

Seibel-Seamon J, Ness A, Goldberg J. Uterine fibroid embolization complications reported in the scientific literature and the FDA’s MAUDE database. NIH 2nd Annual International Fibroid Congress, Bethesda, February 2005.

Bussard A, Goldberg J, McNeil J, Diamond J. Cost and reimbursement for three fibroid treatments: hysterectomy, myomectomy, and uterine fibroid embolization. NIH 2nd Annual International Fibroid Congress, Bethesda, February 2005.

Goldberg J, Worthington-Kirsch R. Uterine artery embolization update. Biosphere Medical investor and board of directors meetings, Boston, May 2004.

Goldberg J, Worthington-Kirsch R. Fibroid embolization: when to refer your patient. Breakfast seminar, ACOG Annual Clinical Meeting, Philadelphia, May 2004.

Goldberg J. Fibroids & fertility: uterine artery embolization and myomectomy. Lunch presentation, ACOG Annual Clinical Meeting, Philadelphia, May 2004.

Goldberg J, Pereira L, Berghella V, Daraï E, Seinera P, Seracchioli R. Pregnancy outcomes following uterine artery embolization versus laparoscopic myomectomy. ACOG Annual Clinical Meeting, Philadelphia, May 2004.

Goldberg J. Pregnancy after myomectomy and uterine artery embolization. Invited speaker. International Federation of Gynecology and Obstetrics (FIGO) World Congress, Santiago, Chile, November 2003.

Goldberg J, Pereira L, Berghella V, Daraï E, Seinera P, Seracchioli R. Pregnancy outcomes following uterine artery embolization versus laparoscopic myomectomy. International Federation of Gynecology and Obstetrics (FIGO) World Congress, Santiago, Chile, November 2003.

Goldberg J. Uterine artery embolization. Lunch presentation, ACOG Clinical Meeting, New Orleans, 2003.

Goldberg J. Uterine artery embolization and the gynecologist. Lunch presentation, ACOG Clinical Meeting, Los Angeles, May 2002.

Goldberg J. Non-hormonal treatment of vaginal bleeding in users of depo-medroxyprogesterone acetate. Magee-Womens Hospital Resident Research Day, Pittsburgh, May 1997.

“Evaluation of infertility”, Magee-Womens Hospital, Pittsburgh, January, 1997.

“Uterine artery embolization: a new frontier in the treatment of uterine fibroids”, Jefferson Medical College Alumni Association Meeting, Whistler, British Columbia, February 5, 2003.

“Fibroids and fertility”, Jefferson Medical College, October 16, 2003.

“Fibroids and fertility”, Albert Einstein Medical Center, October 29, 2003.

“Fibroids and fertility”, Jefferson Medical College Alumni Association Meeting, Park City, Utah, February 2004.

“Uterine fibroids: considerations for the ER doctor”, Jefferson Medical College, March 18, 2004.

“Fibroids: The Jefferson Fibroid Center”, Jefferson Medical College, April 5, 2004.

“Uterine fibroids: treatments and fertility implications”, JeffCare Vorhees, NJ, April 21, 2004.

“Fibroids for the Family Medicine Doctor”, Jefferson Medical College, May 5, 2004.

“Microwave endometrial ablation”, Microsulis, Philadelphia, December 6, 2004.

“Endometrial ablation: through the generations”, Jefferson Medical College, January 19, 2005.

“Uterine fibroid embolization”, Riddle Memorial Hospital, April 21, 2005.

“Uterine fibroid embolization”, Pennsylvania Hospital, July 13, 2005.

“Abnormal uterine bleeding”, Jefferson Medical College Alumni Association Meeting, Park City, Utah, February, 2006.

“Abnormal uterine bleeding”, Symposia Medicus, Winter Conference on Obstetrics and Gynecology, Maui, February, 2006.

“Uterine fibroid embolization”, Symposia Medicus, Winter Conference on Obstetrics and Gynecology, Maui, February, 2006.

“Update on uterine fibroids”, Department of Medicine Grand Rounds, Jefferson Medical College, June 22, 2006.

“Treatment Perspectives for Uterine Fibroids”, Jefferson Medical College, December 7, 2006.

“Uterine fibroid embolization: Friend or Foe?”, Symposia Medicus, Challenges in Gynecology, New York City, December 15, 2006.

“UFE: Friend or foe?”, Symposia Medicus, Big Sky, MT, February 2007.

“UFE”, BioSphere Medical, Inc., Alpharetta, GA, March 21, 2007.

“UFE”, Greater Baltimore Medical Center, Baltimore, MD, April 20, 2007.

“UFE”, Drexel University OB/GYN grand rounds, Philadelphia, May 15, 2007.

“UFE”, Harbor Hospital, Baltimore, MD, June 6, 2007.

“UFE”, Vanderbilt University OB/GYN grand rounds, Nashville, TN, August 3, 2007.

“UFE”, Magee Womens Hospital, Pittsburgh, January 8, 2008.

“UFE: Friend or foe?”, Jefferson Medical College Alumni Meeting, Vail, CO, 2008.

“UFE: Friend or foe?”, Symposia Medicus, Barbados, March 2008.

“GYN risk management case series”, Symposia Medicus, Barbados, March 2008.

“UFE”, Tennessee Nurse Practitioner Society, Memphis, TN, May 20, 2008.

“UFE”, Abington Memorial Hospital, Abington, PA, October 8, 2008.

“Update & treatment options for uterine fibroids”, Symposia Medicus, Challenges in Gynecology, New York City, December 19, 2008.

“UFE”, St. Peter’s University Hospital, New Brunswick, NJ, January 30, 2009.

“UFE”, ACOG Montana Section Annual Clinical Meeting, Big Sky, MT, February 5, 2009.

“Fibroid update 2009”, Symposia Medicus, Los Cabos, Mexico, March 19, 2009.

“Hysterectomy alternatives”, Symposia Medicus, Los Cabos, Mexico, March 20, 2009.

“UFE”, Eastern Shore Medical Symposium, Rehoboth Beach, DE, June 26, 2009.

“Fibroid update 2009”, Symposia Medicus, Las Vegas, September, 2009.

“Risk Management Case Studies”, Symposia Medicus, Las Vegas, September, 2009.

“Fibroid update 2009”, Symposia Medicus, Atlantis Resort, Bahamas, October, 2009.

“Risk Management Case Studies”, Symposia Medicus, Atlantis Resort, Bahamas, October, 2009.

“UFE”, Gynaecological Club of Great Britain and Ireland, Philadelphia, November 9, 2009.

“Evaluation and treatment of pelvic masses”, Jefferson Medical College, February, 2010.

“Risk Management Case Studies”, Symposia Medicus, Cancun, Mexico, March, 2010.

“Mini-laparotomy in GYN surgery”, Jefferson Medical College, April, 2010.

“Risk Management Case Studies”, Symposia Medicus, Jackson Hole, WY, July, 2010.

“Update and treatment options for uterine fibroids”, Symposia Medicus, Jackson Hole, WY, July, 2010.

“Uterine fibroid embolization”, Jefferson Medical College OB/GYN Grand Rounds, October 28, 2010.

“Uterine fibroid embolization”, OB/GYN grand rounds, Oregon Health Sciences University, Portland, OR, November 5, 2010.

“Fibroid update”, Jefferson Family Medicine Grand Rounds, Philadelphia, PA, January 5, 2011.

“Risk Management Case Studies”, Symposia Medicus, Playa del Carmen, Mexico, February, 2011.

“Update and treatment options for uterine fibroids”, Symposia Medicus, Playa del Carmen, Mexico, February, 2011.

“Update for uterine fibroids. Keys to developing a center for uterine fibroids”, University of Virginia, Charlottesville, Virginia, August, 2011.

“Update and treatment options for uterine fibroids”, Jefferson Medical College, Philadelphia, September, 2011.

“Risk Management Case Studies”, Symposia Medicus, St. Thomas, USVI, November, 2011.

“Update and treatment options for uterine fibroids”, Symposia Medicus, St. Thomas, USVI, November, 2011.

“Risk Management Case Studies”, New York City, December, 2011.

“Update and treatment options for uterine fibroids”, Symposia Medicus, New York City, December, 2011.

“Risk Management Case Studies”, Las Vegas, NV, June, 2012.

“Fibroid update”, Symposia Medicus, Atlantis Resort, Bahamas, August, 2012.

“Fibroid update”, Drexel University Department of OB/GYN Grand Rounds, October, 2012.

“Developing an academic career while a full time clinician”, Magee-Womens Hospital Alumni Day, Pittsburgh, October 2012.

“Risk Management Case Studies”, Symposia Medicus, Beaver Creek, Colorado, March, 2013.

“Fibroid update”, Symposia Medicus, Beaver Creek, Colorado, March, 2013.

Updated 4/13